Stocks · Korea 464490 KOSDAQ

QuadMedicine

5,040원 -2.51% Market cap 580억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR1.86x
EPS0 KRW
BPS2,716 KRW
ROE-35.98%
DPS0 KRW

Returns and 52-week range

1W+6.78%
1M+2.86%
3M-15.86%
6M-64.76%
YTD-65.24%
52W high27,150원
52W low4,405원
From 52W high-81.44%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20240원-44억-50억—
20250원-64억-69억—
Quarterly
2024 3Q0원-9억-13억—
2025 1Q0원-34억-34억—
2025 2Q0원33,651,378원-4억—
2026 1Q0원-44억-46억—

Company

CEO백승기
Founded2016-12-23
Fiscal year end12
Address: 경기도 성남시 중원구 사기막골로45번길 14, 제6층 제비-605호(상대원동, 성남우림라이온스밸리2차) &nbsp

Peers in the same sector

CompanyMarket capP/EP/B1M
유유제약605억7.800.54+0.92%
테고사이언스576억—1.13-5.96%
HLB파나진621억—0.86+21.79%
진양제약568억2.200.35+0.00%
팬젠640억30.752.13-4.73%
에이프로젠554억—0.28+3.85%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.